Capital DailyCapital Daily
Finance

Which is Best for Investors: Healthcare Stability (XLV) or Biotech Growth (IBBQ)?

IBBQ surged 54.5% in one year but carries deeper drawdowns. XLV offers broader diversification, lower costs, and double dividend yield for steadier returns.

Which is Best for Investors: Healthcare Stability (XLV) or Biotech Growth (IBBQ)?

Published July 11, 2026 · Category: Finance

Overview

The State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV) provides broad-based exposure to the healthcare sector at lower costs and lower volatility, while the Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) offers focused exposure to the biotechnology subsector with higher historical returns.

Investors seeking healthcare exposure must choose between broad stability and thematic concentration. While both the Invesco fund and the SPDR fund target the healthcare industry, they differ significantly in sub-sector tilts, expense ratios, and historical volatility, making them suitable for different portfolio roles.

Details

Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.